Virios Therapeutics, LLC VIRI

$ 3.88 2710.01%

Quarterly report 2024-Q3
added 11-08-2024

Virios Therapeutics, LLC Financial Statements 2011-2024 | VIRI

Annual Financial Statements Virios Therapeutics, LLC

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	6.57 M	3.54 M	47.1 M	32.8 M	-	-	-	-	-	-	-	-	-
Shares	18.8 M	11.1 M	8.33 M	4.83 M	-	-	-	-	-	-	-	-	-
Historical Prices	0.35	0.32	5.66	6.19	-	-	-	-	-	-	-	-	-
Net Income	-5.3 M	-12.2 M	-16 M	-10.3 M	-2.47 M	-2.11 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-5.45 M	-12.3 M	-15.6 M	-10 M	-	-	-	-	-	-	-	-	-
Interest Expense	151 K	67.5 K	-319 K	-341 K	-	-	-	-	-	-	-	-	-
EBITDA	-5.45 M	-12.3 M	-15.6 M	-	-2.18 M	-1.96 M	-	-	-	-	-	-	-
Operating Expenses	5.45 M	12.3 M	15.6 M	10 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.72 M	4.25 M	4.85 M	9.81 M	1.34 M	1.11 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Virios Therapeutics, LLC

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	1.11 M	22.9 M	770 K	764 K	18.4 M	18.3 M	18.3 M	9.2 M	8.33 M	8.33 M	8.33 M	8.33 M	8.33 M	8.33 M	8.31 M	4.83 M	4.83 M	4.83 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.28 M	-1.05 M	-	-1.24 M	-1.44 M	-1.52 M	-	-2.58 M	-3.67 M	-3.96 M	-	-4.11 M	-4.28 M	-3.06 M	-	-2.72 M	-655 K	-467 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-2.3 M	-1.07 M	-	-1.27 M	-1.48 M	-1.56 M	-	-2.59 M	-3.67 M	-3.96 M	-	-4.11 M	-4.28 M	-3.06 M	-	-2.66 M	-538 K	-383 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	20.5 K	20 K	-	39.2 K	36.3 K	40.4 K	-	16.6 K	4.8 K	906	-	1.51 K	1.5 K	1.4 K	-	-61.2 K	-116 K	-84 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-2.3 M	-1.07 M	-	-1.27 M	-1.48 M	-1.56 M	-	-2.59 M	-3.67 M	-3.96 M	-	-4.11 M	-4.28 M	-3.06 M	-	-2.66 M	-538 K	-383 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	2.3 M	1.07 M	-	1.27 M	1.48 M	1.56 M	-	2.59 M	3.67 M	3.96 M	-	4.11 M	4.28 M	3.06 M	-	2.66 M	538 K	383 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	1.77 M	734 K	-	900 K	919 K	1.06 M	-	970 K	1.27 M	1.19 M	-	1.15 M	1.08 M	1.35 M	-	2.55 M	515 K	352 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency